(1)
Friedmann, PhD, MD, N.; Marsman, PharmD, M. R.; de Kater, PhD, A. W.; Burns, PhD, L. H.; Webster, MD, L. R. A Nasal Abuse Potential Randomized Clinical Trial of REMOXY® ER, a High-Viscosity Extended-Release Oxycodone Formulation. J of Opioid Management 2018, 14, 437-443.